SynthesisAdvances in therapy2022

Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018.

Yifei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.